Clinical Trials Logo

Clinical Trial Summary

This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.


Clinical Trial Description

This study is a placebo-controlled, randomized, double blind, clinical trial to investigate the safety, tolerability and efficacy of the psychedelic dimethyltryptamine (DMT), in addition to a short course of psychotherapy, on Alcohol Use Disorder (AUD). The investigators hypothesize that relative to control (0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion plus psychotherapy), a single psychedelic dose of DMT (plus psychotherapy) in individuals with AUD will 1) be safe and 2) well-tolerated, and 3) reduce alcohol consumption measured in the laboratory the day after, and over the following 8 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06070649
Study type Interventional
Source Yale University
Contact Angelina Contreras
Phone (203) 974-7525
Email angelina.contreras@yale.edu
Status Not yet recruiting
Phase Phase 1
Start date June 1, 2024
Completion date September 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT02911077 - Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Completed NCT04473482 - Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial N/A
Completed NCT03340051 - Remote Alcohol Monitoring and Episodic Thinking N/A
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02388243 - The Computer-based Drug and Alcohol Training Assessment in Kenya N/A
Completed NCT00248612 - Psychosocial and Medication Treatment for Anxiety in Alcoholism Phase 2/Phase 3
Recruiting NCT03535129 - A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder N/A
Completed NCT00142844 - Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Phase 2
Completed NCT00000257 - Effects of Alcohol History on Effects of Nitrous Oxide - 9 N/A
Completed NCT00000278 - Disulfiram for Cocaine-Alcohol Abuse - 3 Phase 2
Recruiting NCT06074341 - TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study N/A
Not yet recruiting NCT05910580 - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years N/A
Completed NCT02655354 - A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity N/A
Completed NCT01227980 - Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ Phase 2
Completed NCT01344122 - Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) N/A
Completed NCT00400010 - Alcohol Expert System Intervention for Problematic Alcohol Use N/A
Completed NCT00391742 - Stepped Interventions for Problem Drinkers N/A
Completed NCT04725552 - Identifying and Managing Alcohol-related Health Problems in General Practice N/A
Completed NCT02968186 - Implementing Screening and Brief Interventions for Excessive Drinkers in Primary Health Care N/A